Compounds > cytidine

Page last updated: 2024-08-17

cytidine and zalcitabine

cytidine has been researched along with zalcitabine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	4 (57.14)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barchi, JJ; Driscoll, JS; Kelley, JA; Marquez, VE; Mitsuya, H; Roth, JS; Shirasaka, T; Siddiqui, MA	1
Borg, N; Ståhle, L	1
Aubertin, AM; Bisagni, E; Dechaux, E; Dollé, V; Grierson, DS; Guillaumel, J; Legraverend, M; Monneret, C; Nguyen, CH; Note, R; Pontikis, R	1
Gaubert, G; Gosselin, G; Maury, G; Salvatori, D; Vincenzetti, S; Vita, A	1
Bacheler, L; Bazmi, H; Diamond, S; Erickson-Viitanen, S; Gallagher, K; Garber, S; Geleziunas, R; Hammond, J; Klabe, R; Liotta, DC; Manion, DJ; Mellors, J; Otto, MJ; Pierce, M; Rayner, M; Schinazi, RF; Stuyver, L; Trainor, G; Wu, JT; Zhang, H	1
Gordon, YJ; Romanowski, EG	1
Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M	1

Other Studies

7 other study(ies) available for cytidine and zalcitabine

Article	Year
Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines. Journal of medicinal chemistry, 1992, Jun-12, Volume: 35, Issue:12 Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Chemical Phenomena; Chemistry, Physical; Cytarabine; Cytidine Deaminase; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Stability; HIV-1; Hydrogen-Ion Concentration; Macaca mulatta; Molecular Structure; Structure-Activity Relationship; Zalcitabine	1992
Pharmacokinetics and distribution over the blood-brain barrier of zalcitabine (2',3'-dideoxycytidine) and BEA005 (2', 3'-dideoxy-3'-hydroxymethylcytidine) in rats, studied by microdialysis. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:9 Topics: Animals; Anti-HIV Agents; Blood-Brain Barrier; Brain; Cytidine; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Zalcitabine	1998
Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase. Journal of medicinal chemistry, 2000, May-18, Volume: 43, Issue:10 Topics: Anti-HIV Agents; Cytidine; Enzyme Inhibitors; HIV Reverse Transcriptase; HIV-1; HIV-2; Molecular Structure; Pyridones; Structure-Activity Relationship; Uracil; Zalcitabine; Zidovudine	2000
Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs. Comparative immunology, microbiology and infectious diseases, 2001, Volume: 24, Issue:2 Topics: Animals; Anti-HIV Agents; Cells, Cultured; Cytidine; Cytopathogenic Effect, Viral; Disease Models, Animal; Dose-Response Relationship, Drug; Sheep; Viral Load; Virus Replication; Visna-maedi virus; Zalcitabine	2001
DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:5 Topics: Animals; Anti-HIV Agents; Cytidine; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Macaca mulatta; Nucleosides; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine	2002
Update on antiviral treatment of adenoviral ocular infections. American journal of ophthalmology, 2008, Volume: 146, Issue:5 Topics: Adenoviridae Infections; Animals; Antiviral Agents; Cytidine; Eye Infections; Humans; Immunoglobulins, Intravenous; Zalcitabine	2008
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice. Antiviral therapy, 2012, Volume: 17, Issue:4 Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine	2012